GPCR activation triggers the release of peptide YY (PYY) and glucagon-like peptide-1 (GLP-1), which delay gastric emptying, enhance satiety, and promote hepatic lipid oxidation, thereby reducing steatosis [10,62,63,64]. The gene discussed is PYY; the disease is steatosis.